Multifunctional Mixed Micelles for Efficient Docetaxol Delivery for Cancer Therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery

Background:

• Docetaxel (DTX) is a potent anticancer drug with limitations in specificity and efficacy.
• Developing targeted drug delivery systems can improve cancer chemotherapy outcomes.
• Functional co-polymers offer versatile platforms for creating advanced nanocarriers.

Purpose of the Study:

• To construct redox-sensitive mixed micelles co-assembled from PEG-PBLG-SS-DTX and PEG-FA.
• To enhance the target specificity and anticancer efficiency of docetaxel (DTX).
• To evaluate the drug release, cellular uptake, and cytotoxicity of the developed mixed micelles.

Main Methods:

• Preparation of mixed micelles using the dialysis method.
• Characterization of micelle size, polydispersity, and critical micelle concentration.
• In vitro drug release studies in the presence and absence of a reducing agent (DTT).
• In vitro cytotoxicity, cellular uptake, and apoptosis assays using MTT, fluorescence microscopy, and flow cytometry on FR-positive and FR-negative cell lines.

Main Results:

• Spherical mixed micelles with a size of 129.7±2.1 nm and low polydispersity (0.10±0.02) were successfully prepared.
• The mixed micelles exhibited excellent self-assembly and stability, with a critical micelle concentration of 5.08 μg/mL.
• DTX release was significantly accelerated in the presence of DTT, indicating redox-sensitivity.
• Folic acid (FA)-targeted micelles showed enhanced cellular uptake and cytotoxicity in folate receptor (FR)-positive MCF-7 cells compared to non-targeted micelles.

Conclusions:

• Redox-sensitive PEG-PBLG-SS-DTX/PEG-FA mixed micelles demonstrate efficient DTX release in response to reducing environments.
• FA-mediated targeting significantly improves cellular uptake and antitumor efficacy in FR-positive cancer cells.
• These targeted mixed micelles represent a promising drug delivery system for enhanced cancer chemotherapy.